Area of expertise: Drug discovery of antibacterials

Michael Barbachyn

Michael Barbachyn

Professor, Brummel Chair in Organic Chemistry
Calvin College
more
Benjamin Blasco

Benjamin Blasco

Senior Discovery Manager
GARDP
more
Mark Blaskovich

Mark Blaskovich

Director of Translation
Institute for Molecular Bioscience, The University of Queensland
more
Mark Brönstrup

Mark Brönstrup

Head of Chemical Biology
Merck & Co.
more
Heike Brötz-Oesterhelt

Heike Brötz-Oesterhelt

Professor of Microbiology, Chair Dept. Microbial Bioactive Compounds,
University of Tübingen
more
Pamela Brown

Pamela Brown

Consultant
Antibacterial Drug Discovery and Medicinal Chemistry
more
Ryan Cirz

Ryan Cirz

Chief Scientific Officer
Revagenix, Inc.
more
Anthony Coates

Anthony Coates

Professor of Medical Microbiology and Founder/CSO
St. George’s University, Helperby Therapeutics
more
James Collins

James Collins

Professor of Medical Engineering & Science and Biological Engineering
Massachusetts Institute of Technology (MIT)
more
Matthew Cooper

Matthew Cooper

Chief Executive Officer
Inflazome
more

Newsletter

Subscribe to our newsletter to stay up-to-date about our webinars, conferences and other activities.



View previous newsletter

Go to Top